459 related articles for article (PubMed ID: 24356798)
1. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
Jung SY; Kim SK; Kim SW; Kwon Y; Lee ES; Kang HS; Ko KL; Shin KH; Lee KS; Park IH; Ro J; Jeong HJ; Joo J; Kang SH; Lee S
Ann Surg Oncol; 2014 Apr; 21(4):1254-9. PubMed ID: 24356798
[TBL] [Abstract][Full Text] [Related]
2. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
Jung SY; Han JH; Park SJ; Lee EG; Kwak J; Kim SH; Lee MH; Lee ES; Kang HS; Lee KS; Park IH; Sim SH; Jeong HJ; Kwon Y; Lee DE; Kim SK; Lee S
Ann Surg Oncol; 2019 Aug; 26(8):2409-2416. PubMed ID: 31065958
[TBL] [Abstract][Full Text] [Related]
3. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
4. Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer.
Fujisawa Y; Nakamura Y; Kawachi Y; Otsuka F
J Surg Oncol; 2012 Jul; 106(1):41-5. PubMed ID: 22252373
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer.
Pitsinis V; Provenzano E; Kaklamanis L; Wishart GC; Benson JR
Surg Oncol; 2015 Dec; 24(4):375-9. PubMed ID: 26555151
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer.
Sugie T; Kinoshita T; Masuda N; Sawada T; Yamauchi A; Kuroi K; Taguchi T; Bando H; Yamashiro H; Lee T; Shinkura N; Kato H; Ikeda T; Yoshimura K; Ueyama H; Toi M
Ann Surg Oncol; 2016 Jan; 23(1):44-50. PubMed ID: 26275781
[TBL] [Abstract][Full Text] [Related]
7. Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer.
Xie F; Zhang D; Cheng L; Yu L; Yang L; Tong F; Liu H; Wang S; Wang S
World J Surg Oncol; 2015 Nov; 13():319. PubMed ID: 26585236
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node pressure in breast cancer.
Nathanson SD; Mahan M
Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green.
Aoyama K; Kamio T; Ohchi T; Nishizawa M; Kameoka S
World J Surg Oncol; 2011 Dec; 9():157. PubMed ID: 22132943
[TBL] [Abstract][Full Text] [Related]
11. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer.
Mieog JS; Troyan SL; Hutteman M; Donohoe KJ; van der Vorst JR; Stockdale A; Liefers GJ; Choi HS; Gibbs-Strauss SL; Putter H; Gioux S; Kuppen PJ; Ashitate Y; Löwik CW; Smit VT; Oketokoun R; Ngo LH; van de Velde CJ; Frangioni JV; Vahrmeijer AL
Ann Surg Oncol; 2011 Sep; 18(9):2483-91. PubMed ID: 21360250
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.
Ji Y; Luo N; Jiang Y; Li Q; Wei W; Yang H; Liu J
J Surg Res; 2017 Jul; 215():88-92. PubMed ID: 28688667
[TBL] [Abstract][Full Text] [Related]
13. Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial.
Valente SA; Al-Hilli Z; Radford DM; Yanda C; Tu C; Grobmyer SR
J Am Coll Surg; 2019 Apr; 228(4):672-678. PubMed ID: 30582975
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.
Thongvitokomarn S; Polchai N
Asian Pac J Cancer Prev; 2020 May; 21(5):1187-1195. PubMed ID: 32458621
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.
van der Vorst JR; Schaafsma BE; Verbeek FP; Hutteman M; Mieog JS; Lowik CW; Liefers GJ; Frangioni JV; van de Velde CJ; Vahrmeijer AL
Ann Surg Oncol; 2012 Dec; 19(13):4104-11. PubMed ID: 22752379
[TBL] [Abstract][Full Text] [Related]
16. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer.
Yararbas U; Argon AM; Yeniay L; Zengel B; Kapkaç M
Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155
[TBL] [Abstract][Full Text] [Related]
17. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
[TBL] [Abstract][Full Text] [Related]
18. Indocyanine green detects sentinel lymph nodes in early breast cancer.
Liu J; Huang L; Wang N; Chen P
J Int Med Res; 2017 Apr; 45(2):514-524. PubMed ID: 28415938
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
Murawa D; Hirche C; Dresel S; Hünerbein M
Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
[TBL] [Abstract][Full Text] [Related]
20. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
